相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Low-dose metformin targets the lysosomal AMPK pathway through PEN2
Teng Ma et al.
NATURE (2022)
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis
Jennifer Chae-Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial
Monika Janda et al.
GYNECOLOGIC ONCOLOGY (2021)
Metformin plus megestrol acetate compared with MA alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial
B-Y Yang et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates
Stefany Acosta-Torres et al.
GYNECOLOGIC ONCOLOGY (2020)
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)
Akira Mitsuhashi et al.
BMJ OPEN (2020)
Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia
Koji Matsuo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer
Bingyi Yang et al.
GYNECOLOGIC ONCOLOGY (2019)
Metformin as a Therapeutic Target in Endometrial Cancers
Teresa Y. Lee et al.
FRONTIERS IN ONCOLOGY (2018)
Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review
Antonio Simone Lagana et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
Effects of metformin on endometrial cancer: Systematic review and meta-analysis
Cinthia G. Meireles et al.
GYNECOLOGIC ONCOLOGY (2017)
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
Francesca Falcone et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
A. Mitsuhashi et al.
ANNALS OF ONCOLOGY (2016)
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
V. N. Sivalingam et al.
BRITISH JOURNAL OF CANCER (2016)
Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
Obiageli Ezewuiro et al.
PLOS ONE (2016)
Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients
Zhou Rong et al.
GYNECOLOGIC ONCOLOGY (2015)
Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature
Sonsoles Alonso et al.
ECANCERMEDICALSCIENCE (2015)
Metformin use and endometrial cancer survival
Nicole S. Nevadunsky et al.
GYNECOLOGIC ONCOLOGY (2014)
Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
Weiwei Shan et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2014)
The Target of Metformin in Type 2 Diabetes
Ele Ferrannini
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
M. A. Pierotti et al.
ONCOGENE (2013)
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis
Ioannis D. Gallos et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Camille C. Gunderson et al.
GYNECOLOGIC ONCOLOGY (2012)
Conservative treatment of early endometrial cancer: Preliminary results of a pilot study
Giuseppe Laurelli et al.
GYNECOLOGIC ONCOLOGY (2011)
Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI Expression
Zhenbo Zhang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells
Ya Xie et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)